G. Henze

8.2k total citations
134 papers, 5.1k citations indexed

About

G. Henze is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, G. Henze has authored 134 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Public Health, Environmental and Occupational Health, 37 papers in Hematology and 36 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in G. Henze's work include Acute Lymphoblastic Leukemia research (70 papers), Childhood Cancer Survivors' Quality of Life (30 papers) and Acute Myeloid Leukemia Research (23 papers). G. Henze is often cited by papers focused on Acute Lymphoblastic Leukemia research (70 papers), Childhood Cancer Survivors' Quality of Life (30 papers) and Acute Myeloid Leukemia Research (23 papers). G. Henze collaborates with scholars based in Germany, Austria and United States. G. Henze's co-authors include Alfred Reiter, Martin Schrappe, M Zimmermann, H. Riehm, Helmut Gadner, F. Lampert, WD Ludwig, J. Ritter, Jochen Harbott and D. Niethammer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

G. Henze

134 papers receiving 4.9k citations

Peers

G. Henze
Peter G. Steinherz United States
William G. Woods United States
Joachim Boos Germany
Barbara L. Asselin United States
Dan Douer United States
Lynne Lennard United Kingdom
G. Henze
Citations per year, relative to G. Henze G. Henze (= 1×) peers Yaddanapudi Ravindranath

Countries citing papers authored by G. Henze

Since Specialization
Citations

This map shows the geographic impact of G. Henze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Henze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Henze more than expected).

Fields of papers citing papers by G. Henze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Henze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Henze. The network helps show where G. Henze may publish in the future.

Co-authorship network of co-authors of G. Henze

This figure shows the co-authorship network connecting the top 25 collaborators of G. Henze. A scholar is included among the top collaborators of G. Henze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Henze. G. Henze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steffen, Ingo G., Christiane Chen‐Santel, Andrej Lissat, et al.. (2024). Prognostic relevance of treatment deviations in children with relapsed acute lymphoblastic leukemia who were treated in the ALL-REZ BFM 2002 study. Leukemia. 39(2). 337–345. 1 indexed citations
2.
Pfluger, Thomas, Kai Uwe Juergens, Regine Kluge, et al.. (2010). Empfehlungen zur Durchführung der Ganz körper-18F-FDG-PET und -PET/CT bei Kindern mit onkologischen Erkrankungen. Nuklearmedizin - NuclearMedicine. 49(6). 225–233. 5 indexed citations
3.
Furth, Christian, Holger Amthauer, Hubertus Hautzel, et al.. (2010). Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma—results for dedicated assessment criteria in a blinded dual-centre read. Annals of Oncology. 22(5). 1198–1203. 31 indexed citations
4.
Herold, Ralf, et al.. (2007). Stand und Bewertung der Strukturen und Ausstattung pädiatrisch-onkologisch-hämatologischer Kliniken. Klinische Pädiatrie. 219(6). 380–390. 1 indexed citations
5.
Wu, Shuling, et al.. (2005). Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia. Cancer. 103(5). 1054–1063. 41 indexed citations
6.
Furth, Christian, Holger Amthauer, Timm Denecke, et al.. (2005). Impact of whole‐body MRI and FDG‐PET on staging and assessment of therapy response in a patient with Ewing sarcoma. Pediatric Blood & Cancer. 47(5). 607–611. 30 indexed citations
7.
Wellmann, Sven, M. Guschmann, Wanja Griethe, et al.. (2004). Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF. Leukemia. 18(5). 926–933. 84 indexed citations
8.
Seeger, K., Karl‐Anton Kreuzer, Tillmann Taube, et al.. (2001). Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.. PubMed. 61(6). 2517–22. 26 indexed citations
9.
Kager, Leo, et al.. (1999). OCCURRENCE OF ACUTE NONLYMPHOBLASTIC LEUKEMIA IN TWO GIRLS AFTER TREATMENT OF RECURRENT, DISSEMINATED LANGERHANS CELL HISTIOCYTOSIS. Pediatric Hematology and Oncology. 16(3). 251–256. 16 indexed citations
10.
Stackelberg, Arend von, et al.. (1999). Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia. European Journal of Cancer. 35(9). 1349–1355. 14 indexed citations
11.
Henze, G., et al.. (1997). Serum S100 – A Marker for Disease Monitoring in Metastatic Melanoma. Dermatology. 194(3). 208–212. 104 indexed citations
12.
Niethammer, D, Thomas Klingebiel, Wolfram Ebell, et al.. (1996). Which children do benefit from bone marrow transplant. Bone Marrow Transplantation. 18. 43–46. 4 indexed citations
13.
Henze, G., et al.. (1995). Die Bedeutung einer präventiven ZNS-Bestrahlung im Rahmen einer antineoplastischen Therapie im Kindesalter hinsichtlich dentogener und mandibulofazialer Spätschäden. Journal of Orofacial Orthopedics / Fortschritte der Kieferorthopädie. 56(5). 254–264. 5 indexed citations
14.
Schutt, Steven, K. Seeger, C. G. Schmidt, W. Siegert, & G. Henze. (1990). Immunoglobulin and T-Cell Receptor Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma. Hämatologie und Bluttransfusion. 33. 56–61. 1 indexed citations
15.
Hartmann, R., et al.. (1990). Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue. European Journal of Clinical Pharmacology. 39(4). 377–383. 37 indexed citations
16.
Bührer, Christoph, et al.. (1990). Central Nervous System Relapse Prevention in 1165 Standard-Risk Children with Acute Lymphoblastic Leukemia in Five BFM Trials. Hämatologie und Bluttransfusion. 33. 500–503. 20 indexed citations
17.
Henze, G., R. Fengler, R. Hartmann, et al.. (1990). BFM Group Treatment Results in Relapsed Childhood Acute Lymphoblastic Leukemia. Hämatologie und Bluttransfusion. 33. 619–626. 17 indexed citations
18.
Creutzig, U., G. Henze, H. Jürgens, et al.. (1987). Hochdosiertes ARA-C in Kombination mit Mitoxantron bei der Therapie der AML im Kindesalter. Oncology Research and Treatment. 10(1). 24–27. 5 indexed citations
19.
Müller-Weihrich, St., G. Henze, H. Langermann, E. Odenwald, & H. Riehm. (1984). Kindliche B-Zell-Lymphome und -Leukämien. Oncology Research and Treatment. 7(4). 205–208. 5 indexed citations
20.
Henze, G., H. Langermann, J. Ritter, G. Schellong, & H. Riehm. (1981). Treatment Strategy for Different Risk Groups in Childhood Acute Lymphoblastic Leukemia: A Report From the BFM Study Group. Hämatologie und Bluttransfusion. 26. 87–93. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026